Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 96,925 | 149,219 | 100,195 | 73,847 | 125,715 |
| Marketable Securities | 215,519 | 171,339 | 153,007 | 189,631 | 152,150 |
| Other current assets | 0 | 10,000 | 10,000 | 0 | 0 |
| TOTAL | $318,127 | $337,199 | $266,151 | $268,606 | $283,175 |
| Non-Current Assets | |||||
| PPE Net | 630 | 683 | 742 | 806 | 867 |
| Other Non-Current Assets | 8,286 | 4,895 | 4,974 | 4,629 | 4,459 |
| TOTAL | $8,916 | $5,578 | $5,716 | $5,435 | $5,326 |
| Total Assets | $327,043 | $342,777 | $271,867 | $274,041 | $288,501 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,083 | 2,727 | 532 | 1,493 | 2,843 |
| Accrued Expenses | 11,822 | 12,304 | 15,362 | 10,586 | 6,304 |
| Other current liabilities | 9,200 | 10,000 | 10,000 | N/A | N/A |
| TOTAL | $22,105 | $25,031 | $25,894 | $12,079 | $9,147 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6 | 34 | 67 | 214 | 360 |
| TOTAL | $6 | $34 | $67 | $214 | $360 |
| Total Liabilities | $22,111 | $25,065 | $25,961 | $12,293 | $9,507 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,237 | 47,037 | 41,348 | 41,212 | 41,151 |
| Common Shares | 47 | 47 | 41 | 41 | 41 |
| Retained earnings | -197,136 | -177,186 | -154,448 | -135,078 | -114,309 |
| Other shareholders' equity | -139 | -53 | 141 | -147 | -111 |
| TOTAL | $304,932 | $317,712 | $245,906 | $261,748 | $278,994 |
| Total Liabilities And Equity | $327,043 | $342,777 | $271,867 | $274,041 | $288,501 |